BioSyent to Present at the LD Micro VI Investor Conference
December 02 2013 - 8:00AM
Marketwired
BioSyent to Present at the LD Micro VI Investor Conference
TORONTO, ONTARIO--(Marketwired - Dec 2, 2013) - BioSyent Inc.
("BioSyent") (TSX-VENTURE:RX) is pleased to announce that CEO René
Goehrum will be making a presentation at the LD Micro VI Investor
Conference at 9am (PT), December 4, 2013 at the Luxe Sunset
Boulevard Hotel in Los Angeles, CA. Mr. Goehrum will provide an
overview of the Company and its corporate activities.
The presentation will be webcast live and may be accessed by
visiting the Investor Center at the www.biosyent.com website or at
the following conference link
http://wsw.com/webcast/ldmicro5/BIOYF. A replay of the webcast will
be available for 365 days after the presentation date.
To view and listen to the CEO presentation commenting on the
Third Quarter 2013 Financial Results released November 21, 2013,
please visit the following link http://www.biosyent.com/q3/.
For a direct market quote (15 minutes delay) for the TSX Venture
Exchange and other Company financial information please visit
www.tmxmoney.com.
About BioSyent Inc.
Listed on the Toronto Venture Exchange under the trading symbol
"RX", BioSyent is a profitable growth oriented specialty
pharmaceutical company which searches the globe to in-license or
acquire innovative pharmaceutical products that have been
successfully developed, are safe and effective, and have a proven
track record of improving the lives of patients and supporting the
healthcare professionals that treat them.
Once a product of interest has been found, BioSyent then
acquires the exclusive rights to the product and manages it through
the Canadian governmental regulatory approval process. Once
approved, BioSyent markets the product throughout Canada.
At the date of this press release the Company had 13,571,195
shares issued and outstanding.
BioSyent Inc.Mr. Rene C. GoehrumPresident and CEO(905)
206-0013investors@biosyent.comwww.biosyent.com
Biosyent (TSXV:RX)
Historical Stock Chart
From May 2024 to Jun 2024
Biosyent (TSXV:RX)
Historical Stock Chart
From Jun 2023 to Jun 2024